In vivo stimulation and restoration of the immune response by the noninflammatory fragment 163-171 of human interleukin 1 beta.
Authors:
Open Access
- 1 August 1988
- journal article
- research article
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 168 (2) , 675-686
Abstract
The synthetic nonapeptide VQGEESNDK, corresponding to the fragment 163-171 of human IL-1 beta, showed in vivo immunomodulatory capacities qualitatively and quantitatively comparable to those of the mature human IL-1 beta protein. In fact, both IL-1 beta and the 163-171 fragment stimulated the immune response of normal mice and restored immune reactivities of immunocompromised animals. In addition, the synthetic IL-1 peptide was as efficient as the entire protein in inducing tumor rejection and radioprotection. On the other hand, the 163-171 fragment did not cause any of several inflammation-associated metabolic changes inducible by the whole IL-1 beta molecule in vivo: hypoferremia, hypoglycemia, hyperinsulinemia, increase in circulating corticosterone, SAA and fibrinogen, decrease in hepatic drug-metabolizing enzymes. Furthermore, at variance with IL-1 beta, the 163-171 peptide did not show the toxic effects causing shock and death in adrenalectomized mice. Thus, these results confirm our previous in vitro observations that functional domains are identifiable within the multipotent cytokine IL-1 beta, and demonstrate the biological relevance of this finding in a variety of in vivo systems. The identification of a selectively active fragment of a cytokine may thus represent a significant step towards a better directed and more rational immunotherapeutic approach.Keywords
This publication has 34 references indexed in Scilit:
- Adrenalectomy sensitizes mice to the lethal effects of interleukin 1 and tumor necrosis factor.Journal of Experimental Medicine, 1988
- Synergy of interleukin 1 and granulocyte colony-stimulating factor: in vivo stimulation of stem-cell recovery and hematopoietic regeneration following 5-fluorouracil treatment of mice.Proceedings of the National Academy of Sciences, 1987
- Minireview Interleukin-1 and osteoarthritisLife Sciences, 1987
- Synthetic C-terminal peptide of IL-1 functions as a binding domain as well as an antagonist for the IL-1 receptorBiochemical and Biophysical Research Communications, 1987
- Determination of the minimum polypeptide lengths of the functionally active sites of human interleukins 1 alpha and 1 beta.Proceedings of the National Academy of Sciences, 1987
- Immunoregulatory Feedback Between Interleukin-1 and Glucocorticoid HormonesScience, 1986
- Accessory Cells and T Cell Activation. The Relationship Between Two Components of Macrophage Accessory Cell Function: I-A and IL1Immunobiology, 1984
- Interleukin-1 and the Pathogenesis of the Acute-Phase ResponseNew England Journal of Medicine, 1984
- In vitro detection of cell‐mediated immunity to individual tumor‐specific antigens of chemically induced BALB/c fibrosarcomasInternational Journal of Cancer, 1983
- The functional relationship of the interleukins.Journal of Experimental Medicine, 1980